Skip to main content
. 2017 Jul 25;7(7):e1179. doi: 10.1038/tp.2017.144

Figure 3.

Figure 3

Reduced EHMT1 mRNA expression and altered gene expression in human induced pluripotent stem cell (hiPSC)-derived neuronal cells from KS-ASD patient on day 10 of terminal differentiation. (a) The mRNA level of EHMT1 transcript variant 1 is reduced in KS-ASD cells compared to CTL1 and CTL2 cells, whereas no change in the level of EHMT1 transcript variant 2 is observed in KS-ASD vs control cells. t-test, CTL1 vs KS-ASD *P=0.0061; CTL2 vs KS-ASD #P=0.0111. Right panel, Western blot analysis of EHMT1 protein expression in CTL1, CTL2 and KS-ASD neurons. GAPDH was used as protein-loading control. (b) Gene expression changes in KS-ASD neurons compared to CTL1 (left) or CTL2 (right) neuronal cells on day 10 of terminal differentiation. Mann–Whitney test, *P<0.05, **P<0.005.